Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 11, 2017
Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas
Mairéad G McNamara, Haiyan Jiang, Mary Jane Lim-Fat, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
September 3, 2008
Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation
Vasantha Atmuri, Dianna C Martin, Richard Hemming, et al.
Advances in Radiation Oncology
|
July 11, 2022
Revisiting the Concept of Recurrence of Primary Central Nervous System Lymphomas After Complete Response to Methotrexate-Based Therapy: Periventricular Reseeding as the Predominant Mechanism of Recurrence
Tugce Kutuk, G Daniel Grass, Daniel Oliver, et al.
Clinical Pharmacology in Drug Development
|
November 16, 2022
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors
Xiaofei Zhou, Debra L Richardson, Afshin Dowlati, et al.
Neuro-Oncology Advances
|
April 11, 2022
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies
Yazmin Odia, Ludimila Cavalcante, Howard Safran, et al.
Melanoma Research
|
June 11, 2016
A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature
Inna V Fedorenko, Brittany Evernden, Rajappa S Kenchappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors
Mrinal M Gounder, Lakshmi Nayak, Solmaz Sahebjam, et al.
Breast Cancer Research and Treatment
|
February 3, 2018
Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience
Nicholas B Figura, Wendy Long, Michael Yu, et al.
Journal for Immunotherapy of Cancer
|
March 15, 2022
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study
Aung Naing, John D Powderly, John J Nemunaitis, et al.
Neuro-Oncology
|
November 7, 2017
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro, Gordana Vlahovic, Michael Lim, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
May 11, 2017
Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas
Mairéad G McNamara, Haiyan Jiang, Mary Jane Lim-Fat, et al.
Matrix Biology : Journal of the International Society for Matrix Biology
|
September 3, 2008
Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation
Vasantha Atmuri, Dianna C Martin, Richard Hemming, et al.
Advances in Radiation Oncology
|
July 11, 2022
Revisiting the Concept of Recurrence of Primary Central Nervous System Lymphomas After Complete Response to Methotrexate-Based Therapy: Periventricular Reseeding as the Predominant Mechanism of Recurrence
Tugce Kutuk, G Daniel Grass, Daniel Oliver, et al.
Clinical Pharmacology in Drug Development
|
November 16, 2022
Effect of Pevonedistat, an Investigational NEDD8-Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors
Xiaofei Zhou, Debra L Richardson, Afshin Dowlati, et al.
Neuro-Oncology Advances
|
April 11, 2022
Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies
Yazmin Odia, Ludimila Cavalcante, Howard Safran, et al.
Melanoma Research
|
June 11, 2016
A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature
Inna V Fedorenko, Brittany Evernden, Rajappa S Kenchappa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2015
Evaluation of the Safety and Benefit of Phase I Oncology Trials for Patients With Primary CNS Tumors
Mrinal M Gounder, Lakshmi Nayak, Solmaz Sahebjam, et al.
Breast Cancer Research and Treatment
|
February 3, 2018
Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience
Nicholas B Figura, Wendy Long, Michael Yu, et al.
Journal for Immunotherapy of Cancer
|
March 15, 2022
Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study
Aung Naing, John D Powderly, John J Nemunaitis, et al.
Neuro-Oncology
|
November 7, 2017
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro, Gordana Vlahovic, Michael Lim, et al.
Page
of 9